Medicare’s Drug-Pricing Experiment Stirs Opposition

Kaiser Health News: A broad proposal by Medicare to change the way it pays for some drugs has drawn intense reaction and lobbying, with much of the debate centering on whether the plan gives too much power over drug prices to government regulators.

Read article